TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate nea...Show More
peer of
competitor of
Metrics
marketSTOCKS
msh_idCOM:TRANSMEDICS
localeus
websitehttps://www.transmedics.com/
ipo_date2019-05-02
primary_stock_msh_idNASDAQ:TMDX
source_reff30f5dc1-ccd8-45d7-9c91-c703a0aec800
products_or_servicesOrgan Care System, OCS™ Lung, OCS™ Heart, OCS™ Liver, National OCS Program